Q3 EPS Estimates for Teladoc Health Raised by Zacks Research

Key Points

• Zacks Research has upgraded its Q3 2025 earnings per share (EPS) estimate for Teladoc Health from ($0.25) to ($0.24).
• Teladoc reported a Q2 EPS of ($0.19), beating the consensus estimate of ($0.27) by $0.08, while revenue for the quarter was $631.90 million, slightly above expectations.
• Several financial institutions have recently lowered their price targets for Teladoc, with a consensus average rating of "Hold" and an average price target of $9.76.

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Stock analysts at Zacks Research upped their Q3 2025 earnings per share estimates for Teladoc Health in a research note issued to investors on Tuesday, August 12th. Zacks Research analyst R. Department now forecasts that the health services provider will post earnings of ($0.24) per share for the quarter, up from their previous forecast of ($0.25). The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health's Q4 2025 earnings at ($0.18) EPS, FY2025 earnings at ($0.80) EPS, Q1 2026 earnings at ($0.29) EPS, Q2 2026 earnings at ($0.24) EPS, Q3 2026 earnings at ($0.27) EPS, Q4 2026 earnings at ($0.13) EPS, FY2026 earnings at ($0.93) EPS, Q1 2027 earnings at ($0.26) EPS, Q2 2027 earnings at ($0.23) EPS and FY2027 earnings at ($0.92) EPS.

Other equities analysts have also issued reports about the company. The Goldman Sachs Group dropped their price target on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Jefferies Financial Group reduced their price target on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Bank of America reduced their price target on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Finally, Evercore ISI increased their price target on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Seven investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $9.76.

Teladoc Health Stock Performance

NYSE:TDOC traded down $0.0330 during mid-day trading on Thursday, hitting $7.4570. 2,293,576 shares of the company traded hands, compared to its average volume of 6,980,469. The stock's fifty day moving average price is $7.72 and its 200-day moving average price is $8.28. Teladoc Health has a one year low of $6.35 and a one year high of $15.21. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of -6.27 and a beta of 1.76.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.08. The firm had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company's revenue was down 1.6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently modified their holdings of the business. Mercer Global Advisors Inc. ADV increased its stake in shares of Teladoc Health by 9.6% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock valued at $113,000 after purchasing an additional 1,089 shares in the last quarter. Canada Pension Plan Investment Board boosted its holdings in Teladoc Health by 0.5% in the 4th quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider's stock worth $2,079,000 after buying an additional 1,200 shares during the last quarter. Summit Investment Advisors Inc. boosted its holdings in Teladoc Health by 8.0% in the 4th quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider's stock worth $164,000 after buying an additional 1,331 shares during the last quarter. Vise Technologies Inc. boosted its holdings in shares of Teladoc Health by 4.9% during the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock worth $274,000 after purchasing an additional 1,405 shares during the last quarter. Finally, Teacher Retirement System of Texas boosted its holdings in shares of Teladoc Health by 5.7% during the 2nd quarter. Teacher Retirement System of Texas now owns 26,592 shares of the health services provider's stock worth $232,000 after purchasing an additional 1,431 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of the stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the sale, the insider owned 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 5,808 shares of the firm's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the completion of the sale, the insider directly owned 69,773 shares of the company's stock, valued at $478,642.78. The trade was a 7.68% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is currently owned by corporate insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.